Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).

Bacchi E, Negri C, Targher G, Faccioli N, Lanza M, Zoppini G, Zanolin E, Schena F, Bonora E, Moghetti P.

Hepatology. 2013 Oct;58(4):1287-95. doi: 10.1002/hep.26393. Epub 2013 Aug 22.

PMID:
23504926
2.

Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.

Croci I, Byrne NM, Choquette S, Hills AP, Chachay VS, Clouston AD, O'Moore-Sullivan TM, Macdonald GA, Prins JB, Hickman IJ.

Gut. 2013 Nov;62(11):1625-33. doi: 10.1136/gutjnl-2012-302789. Epub 2012 Oct 17.

PMID:
23077135
3.

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Järvinen H.

Gastroenterology. 2008 Jul;135(1):122-30. doi: 10.1053/j.gastro.2008.03.021. Epub 2008 Mar 21.

PMID:
18474251
4.

Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study).

Bacchi E, Negri C, Zanolin ME, Milanese C, Faccioli N, Trombetta M, Zoppini G, Cevese A, Bonadonna RC, Schena F, Bonora E, Lanza M, Moghetti P.

Diabetes Care. 2012 Apr;35(4):676-82. doi: 10.2337/dc11-1655. Epub 2012 Feb 16.

5.

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA.

Gastroenterology. 2007 Aug;133(2):496-506. Epub 2007 May 1.

PMID:
17681171
6.

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.

Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N.

Diabetes. 2001 Aug;50(8):1844-50.

7.

Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.

Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P.

Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E282-90. Epub 2006 Feb 14.

8.

Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.

Fishbein MH, Mogren C, Gleason T, Stevens WR.

J Pediatr Gastroenterol Nutr. 2006 Jan;42(1):83-8.

PMID:
16385259
9.

Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.

Llauradó G, Sevastianova K, Sädevirta S, Hakkarainen A, Lundbom N, Orho-Melander M, Groop PH, Forsblom C, Yki-Järvinen H.

J Clin Endocrinol Metab. 2015 Feb;100(2):607-16. doi: 10.1210/jc.2014-3050. Epub 2014 Nov 18.

PMID:
25405502
10.

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.

Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA.

Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1135-43.

11.

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.

Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, Königsrainer A, Königsrainer I, Kröber S, Niess A, Fritsche A, Häring HU, Stefan N.

Gut. 2009 Sep;58(9):1281-8. doi: 10.1136/gut.2008.151977. Epub 2008 Dec 11.

PMID:
19074179
12.

Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.

Markova M, Pivovarova O, Hornemann S, Sucher S, Frahnow T, Wegner K, Machann J, Petzke KJ, Hierholzer J, Lichtinghagen R, Herder C, Carstensen-Kirberg M, Roden M, Rudovich N, Klaus S, Thomann R, Schneeweiss R, Rohn S, Pfeiffer AF.

Gastroenterology. 2017 Feb;152(3):571-585.e8. doi: 10.1053/j.gastro.2016.10.007. Epub 2016 Oct 17.

PMID:
27765690
13.

A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents.

van der Heijden GJ, Wang ZJ, Chu ZD, Sauer PJ, Haymond MW, Rodriguez LM, Sunehag AL.

Obesity (Silver Spring). 2010 Feb;18(2):384-90. doi: 10.1038/oby.2009.274. Epub 2009 Aug 20. Erratum in: Obesity (Silver Spring). 2010 May;18(5):1062.

14.

Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Guerrero R, Vega GL, Grundy SM, Browning JD.

Hepatology. 2009 Mar;49(3):791-801. doi: 10.1002/hep.22726.

15.

Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.

Rijzewijk LJ, van der Meer RW, Lubberink M, Lamb HJ, Romijn JA, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M.

Diabetes. 2010 Nov;59(11):2747-54. doi: 10.2337/db09-1201. Epub 2010 Aug 6.

16.

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, George J.

Hepatology. 2009 Oct;50(4):1105-12. doi: 10.1002/hep.23129.

PMID:
19637289
17.

Effects of resistance or aerobic exercise training on interleukin-6, C-reactive protein, and body composition.

Donges CE, Duffield R, Drinkwater EJ.

Med Sci Sports Exerc. 2010 Feb;42(2):304-13. doi: 10.1249/MSS.0b013e3181b117ca.

PMID:
20083961
18.
19.

The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.

Goto T, Onuma T, Takebe K, Kral JG.

Int J Obes Relat Metab Disord. 1995 Dec;19(12):841-5.

PMID:
8963349
20.

The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.

Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, O'Dea K, Desmond PV, Johnson NA, Wilson AM.

J Hepatol. 2013 Jul;59(1):138-43. doi: 10.1016/j.jhep.2013.02.012. Epub 2013 Feb 26.

PMID:
23485520

Supplemental Content

Support Center